Literature DB >> 24960620

Treating rheumatoid arthritis to target: an Italian rheumatologists' survey on the acceptance of the treat-to-target recommendations.

Roberto Caporali1, Fabrizio Conti, Michele Covelli, Marcello Govoni, Fausto Salaffi, Giuseppe Ventriglia, Carlomaurizio Montecucco.   

Abstract

OBJECTIVES: An educational programme was conducted in Italy in order to favour the diffusion of the rheumatoid arthritis (RA) treat-to-target (T2T) recommendations among Italian rheumatologists. Our objective was to measure the level of acceptance and applicability of the 10 recommendations to treat RA to a target of remission/low disease activity in the Italian rheumatology community, before and after the educational programme.
METHODS: One hundred rheumatologists working throughout Italy were invited to participate in this two-stage web-based survey (S1-2). Three questions concerning agreement with, applicability of and possible barriers to the applicability of each of the ten T2T recommendations were administered before (S1) and after (S2) an educational event on the T2T strategy in RA. The agreement with each of the 10 recommendations was measured by a 10-point Likert scale. The applicability of each recommendation was assessed by a 5-point Likert scale (never, almost never, sometimes, almost always, always). Finally, three possible barriers to each recommendation applicability were identified.
RESULTS: Seventy-one rheumatologists participated in S1 and 61 in S2. Level of agreement was high (mean score: 8.9 in S1, 9.1 in S2), with each recommendation receiving a score ≥7.9. The highest agreement score was achieved by recommendation 7 in both surveys. Recommendation 8 received the lowest overall agreement in both surveys. Concerning applicability, the majority of responses was 'almost always'. Following the educational programme, the mean degree of agreement with the recommendations increased significantly for recommendations 3, 4, 6, and 10.
CONCLUSIONS: The level of knowledge of and agreement with the T2T recommendations for RA among Italian rheumatologists is high and increased significantly for some recommendations following a specific educational event, indicating that a deeper knowledge of the T2T strategy may increase agreement and acceptance.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24960620

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  8 in total

1.  Putting recommendations into practice: Australian rheumatologists' opinions on leflunomide use in rheumatoid arthritis.

Authors:  Ashley M Hopkins; Michael D Wiese; Catherine E O'Doherty; Susanna M Proudman
Journal:  Clin Rheumatol       Date:  2016-11-25       Impact factor: 2.980

2.  Factors associated with the intensification of treatment in rheumatoid arthritis in clinical practice.

Authors:  Antonio Naranjo; Laura Cáceres; José Ángel Hernández-Beriaín; Félix Francisco; Soledad Ojeda; Sigrid Talaverano; Javier Nóvoa-Medina; José Adán Martín; Esmeralda Delgado; Elisa Trujillo; Fátima Álvarez; Laura Magdalena; Carlos Rodríguez-Lozano
Journal:  Rheumatol Int       Date:  2015-08-04       Impact factor: 2.631

3.  Magnetic resonance imaging of the craniovertebral junction in early rheumatoid arthritis.

Authors:  Marina Carotti; Fausto Salaffi; Marco Di Carlo; Francesco Sessa; Andrea Giovagnoni
Journal:  Skeletal Radiol       Date:  2018-09-11       Impact factor: 2.199

4.  Patient Acceptable Symptom State in Self-Report Questionnaires and Composite Clinical Disease Index for Assessing Rheumatoid Arthritis Activity: Identification of Cut-Off Points for Routine Care.

Authors:  Fausto Salaffi; Marina Carotti; Marwin Gutierrez; Marco Di Carlo; Rossella De Angelis
Journal:  Biomed Res Int       Date:  2015-06-18       Impact factor: 3.411

5.  Factors influencing the use of biologic therapy and adoption of treat-to-target recommendations in current European rheumatology practice.

Authors:  Peter C Taylor; Rieke Alten; Juan J Gomez Reino; Roberto Caporali; Philippe Bertin; Emma Sullivan; Robert Wood; James Piercy; Radu Vasilescu; Dean Spurden; Jose Alvir; Miriam Tarallo
Journal:  Patient Prefer Adherence       Date:  2018-10-04       Impact factor: 2.711

6.  New Rheumatoid Arthritis Treatments for 'Old' Patients: Results of a Systematic Review.

Authors:  Roberto Caporali; Walid K H Fakhouri; Claudia Nicolay; Harriet J Longley; Serena Losi; Veronica Rogai
Journal:  Adv Ther       Date:  2020-07-23       Impact factor: 3.845

Review 7.  Rheumatoid arthritis treatment: the earlier the better to prevent joint damage.

Authors:  Sara Monti; Carlomaurizio Montecucco; Serena Bugatti; Roberto Caporali
Journal:  RMD Open       Date:  2015-08-15

8.  Effectiveness of a telemonitoring intensive strategy in early rheumatoid arthritis: comparison with the conventional management approach.

Authors:  Fausto Salaffi; Marina Carotti; Alessandro Ciapetti; Marco Di Carlo; Stefania Gasparini; Sonia Farah; Marwin Gutierrez
Journal:  BMC Musculoskelet Disord       Date:  2016-04-02       Impact factor: 2.362

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.